Alexandra Mancini

2024

In 2024, Alexandra Mancini earned a total compensation of $313.6K as Senior Vice President, Clinical & Regulatory Affairs at InMed Pharmaceuticals, a 10% increase compared to previous year.

Compensation breakdown

Bonus$36,800
Option Awards$15,800
Salary$261,000
Total$313,600

Mancini received $261K in salary, accounting for 83% of the total pay in 2024.

Mancini also received $36.8K in bonus and $15.8K in option awards.

Rankings

In 2024, Alexandra Mancini's compensation ranked 164th out of 207 executives tracked by ExecPay. In other words, Mancini earned more than 20.8% of executives.

ClassificationRankingPercentile
All
164
out of 207
21st
Division
Manufacturing
67
out of 89
25th
Major group
Chemicals And Allied Products
30
out of 36
17th
Industry group
Drugs
30
out of 33
9th
Industry
Pharmaceutical Preparations
28
out of 30
7th
Source: SEC filing on October 28, 2024.

Mancini's colleagues

We found five more compensation records of executives working with Alexandra Mancini at InMed Pharmaceuticals in 2024.

2024

Eric Adams

InMed Pharmaceuticals

Chief Executive Officer

2024

Michael Woudenberg

InMed Pharmaceuticals

Chief Operating Officer

2024

Eric Hsu

InMed Pharmaceuticals

Senior Vice President, Preclinical Research & Development

2024

Netta Jagpal

InMed Pharmaceuticals

Chief Financial Officer

2024

Jonathan Tegge

InMed Pharmaceuticals

Chief Financial Officer

News

You may also like